Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85.4M Buy
833,600
+283,600
+52% +$28.9M 4.94% 8
2025
Q4
$55.3M Sell
550,000
-850,000
-61% -$83.8M 3.68% 13
2025
Q3
$121M Buy
1,400,000
+25,000
+2% +$1.98M 5.91% 2
2025
Q2
$105M Sell
1,375,000
-480,000
-26% -$35.1M 7.41% 2
2025
Q1
$132M Buy
1,855,000
+233,400
+14% +$18.2M 9.69% 2
2024
Q4
$127M Buy
1,621,600
+681,600
+73% +$63.7M 9.3% 3
2024
Q3
$96.2M Sell
940,000
-547,756
-37% -$45.4M 6.01% 6
2024
Q2
$113M Hold
1,487,756
7.7% 2
2024
Q1
$112M Buy
1,487,756
+156,719
+12% +$12.5M 7.47% 3
2023
Q4
$98M Buy
1,331,037
+502,259
+61% +$31.1M 8.56% 3
2023
Q3
$38.1M Sell
828,778
-321,222
-28% -$14.3M 4.45% 11
2023
Q2
$48.5M Buy
1,150,000
+75,000
+7% +$2.84M 5.45% 9
2023
Q1
$28M Buy
1,075,000
+161,379
+18% +$4.77M 4.27% 9
2022
Q4
$27.2M Buy
+913,621
New +$25.5M 4.1% 9

Other funds holding NUVL

Commodore Capital's NUVL Position: Q1 2026 in Review

Commodore Capital increased its Nuvalent (NUVL) stake by 52% in Q1 2026, buying an estimated $28.9M and bringing the position to 833,600 shares worth $85.4M. The position accounts for 4.94% of the portfolio, ranked #8.

Commodore Capital first reported a position in NUVL in Q4 2022 and has held it in 14 quarters since. The position peaked at $132M in Q1 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Commodore Capital held 833,600 shares of Nuvalent worth $85.4M as of Q1 2026.
  • Commodore Capital bought 283,600 Nuvalent shares in Q1 2026, an estimated $28.9M.
  • Nuvalent made up 4.94% of Commodore Capital's portfolio in Q1 2026, its #8 holding.
  • Commodore Capital first reported a position in Nuvalent in Q4 2022 and has held it in 14 quarters since.
  • Commodore Capital's Nuvalent position peaked at $132M in Q1 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Commodore Capital's 13F filing for Q1 2026, filed 15 May 2026.